MyFinsight
Home
Blog
About
Back
Income Statement
Milestone Pharmaceuticals Inc. (MIST)
Milestone Pharmaceuticals Inc. (MIST)
source: myfinsight.com
Net loss and
comprehensive loss
-$28,614,000
(-120.68%↓ Y/Y)
Interest income
$1,741,000
(237.40%↑ Y/Y)
Loss from operations
-$25,630,000
(-104.53%↓ Y/Y)
Interest expense
$4,725,000
(396.85%↑ Y/Y)
Total revenues
$559,000
Total operating
expenses
$26,189,000
Selling, general and
administrative
$22,648,000
Research and
development, net of tax...
$3,509,000
(-4.36%↓ Y/Y)
Cost of product sales
$32,000
Back